On June 9, Qingsong Health (02661.HK) fell 8.21% in regular trading, trading at HKD 15.16/share, with trading volume of approximately HKD 40.74 million. This marks a second consecutive session of sharp decline following an 8.9% drop on June 8.

On the news front, the company's June lock-up expiry period is approaching, fueling persistent market anxiety. Previously on June 5, the stock surged over 33% on news of its AI product Zheng Yuanfang being integrated into the Yilu Qingsong platform, but the rally was quickly reversed. The company's shareholding structure is highly concentrated among a small number of shareholders, with extremely low average daily trading volume. Prior filings have explicitly warned that even minimal buy or sell orders could trigger significant price swings.

Since its historical high in March, the stock has cumulatively lost over 85% of its value. Under the dual constraints of imminent lock-up expiry pressure and insufficient liquidity, the stock continues its weak trajectory.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)